Hantz Financial Services, Inc. Horizon Therapeutics Public LTD CO Transaction History

Hantz Financial Services, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 06, 2024	BUY	$98.98 - $115.74 $70,968 - $82,985	717 Added 40.6%	2,483 $287,000
Q2 2023 Aug 06, 2024	SELL	$96.34 - $112.38 $215,608 - $251,506	-2,238 Reduced 55.89%	1,766 $182,000
Q1 2023 Aug 06, 2024	SELL	$107.32 - $113.5 $15.6 Million - $16.5 Million	-145,111 Reduced 97.31%	4,004 $437,000
Q4 2022 Aug 06, 2024	BUY	$62.39 - $113.8 $106,811 - $194,825	1,712 Added 1.16%	149,115 $17 Million
Q3 2022 Aug 06, 2024	SELL	$58.92 - $84.67 $280,341 - $402,859	-4,758 Reduced 3.13%	147,403 $9.12 Million
Q2 2022 Aug 06, 2024	BUY	$79.4 - $116.36 $165,390 - $242,377	2,083 Added 1.39%	152,161 $12.1 Million
Q1 2022 Aug 06, 2024	BUY	$86.42 - $109.81 $985,447 - $1.25 Million	11,403 Added 8.22%	150,078 $15.8 Million
Q4 2021 Aug 06, 2024	BUY	$98.56 - $119.91 $990,035 - $1.2 Million	10,045 Added 7.81%	138,675 $14.9 Million
Q3 2021 Aug 06, 2024	BUY	$91.91 - $110.37 $1.76 Million - $2.11 Million	19,103 Added 17.44%	128,630 $14.1 Million
Q2 2021 Aug 06, 2024	BUY	$86.24 - $95.92 $641,108 - $713,069	7,434 Added 7.28%	109,527 $10.3 Million
Q1 2021 Aug 06, 2024	BUY	$71.83 - $95.48 $7.33 Million - $9.75 Million	102,093 New	102,093 $9.4 Million
Q4 2020 Aug 06, 2024	BUY	$67.0 - $84.39 $186,193 - $234,519	2,779 Added 3.0%	95,278 $6.97 Million
Q3 2020 Aug 06, 2024	BUY	$55.23 - $79.93 $97,978 - $141,795	1,774 Added 1.96%	92,499 $7.19 Million
Q2 2020 Aug 06, 2024	BUY	$30.2 - $56.98 $2.74 Million - $5.17 Million	90,725 New	90,725 $5.04 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.